
Francis Biotech India Private Limited.
Founded in 2001 and headquartered in Delhi, India.
Founded in 2001 and headquartered in Delhi, India.
South Delhi, Delhi, India
+91-XXXXXXXXXX
U24231DL2001PTC112205
112205
Private Limited Indian Non-Government Company
27 Aug 2001
29 Sep 2012
31 Mar 2012
Unlisted
Roc-Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Anuj Singh ![]() | Director | 27-Aug-2001 | Current |
Gaurav Ahlawat ![]() | Director | 27-Aug-2001 | Current |
Enhance accessibility to Francis Biotech India's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Francis Biotech India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Gaurav Ahlawat is a mutual person
Gaurav Ahlawat is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Francis Biotech India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Francis Biotech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Francis Biotech India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Francis Biotech India Private Limited. last Annual general meeting of members was held on 29 Sep 2012 as per latest MCA records.
Francis Biotech India Private Limited. has filed its annual Financial statements for the year ended 31 Mar 2012 with RoC-Delhi.
Anuj Singh was appointed as a Director was appointed as a Director on 27 Aug 2001 & has been associated with this company since 23 years 6 months .
Gaurav Ahlawat was appointed as a Director was appointed as a Director on 27 Aug 2001 & has been associated with this company since 23 years 6 months .
Francis Biotech India Private Limited. was registered on 27 Aug 2001 with RoC-Delhi & aged 23 years 6 months as per MCA records.
Francis Biotech India Private Limited. was incorporated on 27 Aug 2001.
The authorized share capital of Francis Biotech India Private Limited. is ₹ 0.50 M and paid-up capital is ₹ 0.50 M.
Currently 2 directors are associated with Francis Biotech India Private Limited..
As per Ministry of Corporate Affairs (Mca), the registered address of Francis Biotech India Private Limited. is M-29 G.K-In.Delhi-48, New Delhi, India, 110048.
The corporate identification number (CIN) of Francis Biotech India Private Limited. is U24231DL2001PTC112205 and the company number is 112205 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Francis Biotech India Private Limited. was filed with the ROC on 31 Mar 2012.
Search company & director profiles for free and gain access to critical business data.